Innovating for Healthier Lives

Zhenzhu Pharma is dedicated to improving human health through scientific innovation and high-quality pharmaceutical products.

Learn More

About Zhenzhu Pharma

We are a global pharmaceutical company focused on innovative drug development, dedicated to improving human health through science.

Excellence in Quality

Strict adherence to international GMP standards ensures every product meets the highest quality requirements for patient safety.

Innovative R&D

Significant investment in drug research with multiple projects in development, focusing on unmet medical needs.

Global Presence

Operations across multiple countries and regions, collaborating with local healthcare providers to serve patients worldwide.

Our Products

Our research pipeline covers multiple therapeutic areas, dedicated to providing innovative treatment solutions.

Cardiovascular

Focused on developing treatments for hypertension, coronary heart disease, and other cardiovascular conditions.

Oncology

Developing innovative targeted therapies for various types of cancer.

Immunology

Researching novel immunomodulators for treating autoimmune diseases.

Neurology

Focused on treatments for neurodegenerative diseases and mental health disorders.

Innovation Center

Innovation Center

Our R&D center is equipped with world-class facilities and professional teams, dedicated to advancing pharmaceutical science.

  • Advanced Facilities: International standard laboratories and research equipment
  • Expert Team: Bringing together top pharmaceutical research talent globally
  • Collaborative Network: Strategic partnerships with leading research institutions
  • Continuous Investment: 20% of annual revenue dedicated to R&D innovation

Latest News

Stay updated with Zhenzhu Pharma's latest developments and industry insights.

March 15, 2024

Zhenzhu Pharma Announces Phase III Clinical Trial for Novel Cancer Drug

Our self-developed targeted therapy ZZP-001 has received regulatory approval to enter Phase III clinical trials, offering new hope for cancer patients.

February 28, 2024

Strategic Partnership with Leading European Pharmaceutical Company

Zhenzhu Pharma signs strategic agreement with a leading European pharmaceutical company to jointly develop and market cardiovascular treatments.

January 10, 2024

Recognized as "Innovative Pharmaceutical Company of the Year"

At the 2024 Global Pharmaceutical Innovation Summit, Zhenzhu Pharma was honored with the "Innovative Pharmaceutical Company of the Year" award.

Subscribe to Our Newsletter

Get the latest company updates and industry news delivered to your inbox.